These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17549378

  • 41. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM, Hoffman HT, Robinson RA.
    J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
    [Abstract] [Full Text] [Related]

  • 42. [Changes of p16 gene, cyclin D1 gene, and pRb protein in human pancreatic adenocarcinoma cell lines].
    Xu Y, Chen J, Liu T, Gu L, Gao J, Li L.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):566-9. PubMed ID: 12903406
    [Abstract] [Full Text] [Related]

  • 43. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
    Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J.
    Cancer Res; 1995 Feb 15; 55(4):949-56. PubMed ID: 7850812
    [Abstract] [Full Text] [Related]

  • 44. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
    Lerma E, Esteller M, Herman JG, Prat J.
    Hum Pathol; 2002 Nov 15; 33(11):1120-5. PubMed ID: 12454817
    [Abstract] [Full Text] [Related]

  • 45. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 46. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.
    Krecicki T, Smigiel R, Fraczek M, Kowalczyk M, Sasiadek MM.
    J Laryngol Otol; 2004 Sep 08; 118(9):676-80. PubMed ID: 15509364
    [Abstract] [Full Text] [Related]

  • 47. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
    de vos tot Nederveen Cappel WH, Offerhaus GJ, van Puijenbroek M, Caspers E, Gruis NA, De Snoo FA, Lamers CB, Griffioen G, Bergman W, Vasen HF, Morreau H.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3598-605. PubMed ID: 14506146
    [Abstract] [Full Text] [Related]

  • 48. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
    Rocco JW, Li D, Liggett WH, Duan L, Saunders JK, Sidransky D, O'Malley BW.
    Clin Cancer Res; 1998 Jul 01; 4(7):1697-704. PubMed ID: 9676844
    [Abstract] [Full Text] [Related]

  • 49. Mutations of the INK4a locus in squamous cell carcinomas of human skin.
    Kubo Y, Urano Y, Matsumoto K, Ahsan K, Arase S.
    Biochem Biophys Res Commun; 1997 Mar 06; 232(1):38-41. PubMed ID: 9125147
    [Abstract] [Full Text] [Related]

  • 50. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes.
    Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, Edington KG, Ly IS, Simmons R, Haw R, Black DM, Newbold RF, Parkinson EK.
    Oncogene; 1997 Apr 24; 14(16):1955-64. PubMed ID: 9150362
    [Abstract] [Full Text] [Related]

  • 51. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
    Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Smith TL, Gardner LA, Ritt MG, Bell JS, Freeman KP, Greenfield BE, Lana SE, Kisseberth WC, Helfand SC, Cutter GR, Breen M, Modiano JF.
    Vet Pathol; 2007 Jul 24; 44(4):467-78. PubMed ID: 17606508
    [Abstract] [Full Text] [Related]

  • 52. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
    Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, Wennerberg J.
    Int J Oncol; 2002 Jan 24; 20(1):45-52. PubMed ID: 11743641
    [Abstract] [Full Text] [Related]

  • 53. Frequent inactivation of p16INK4a in oral premalignant lesions.
    Papadimitrakopoulou V, Izzo J, Lippman SM, Lee JS, Fan YH, Clayman G, Ro JY, Hittelman WN, Lotan R, Hong WK, Mao L.
    Oncogene; 1997 Apr 17; 14(15):1799-803. PubMed ID: 9150385
    [Abstract] [Full Text] [Related]

  • 54. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
    Leng K, Schlien S, Bosch FX.
    J Oral Pathol Med; 2006 Jan 17; 35(1):19-24. PubMed ID: 16393249
    [Abstract] [Full Text] [Related]

  • 55. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A, Oda Y, Kurihara S, Ohishi Y, Yasunaga M, Nishimura I, Takagi E, Kobayashi H, Wake N, Tsuneyoshi M.
    Pathol Int; 2008 Dec 17; 58(12):757-64. PubMed ID: 19067849
    [Abstract] [Full Text] [Related]

  • 56. p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach.
    Lee WA, Woo DK, Kim YI, Kim WH.
    Pathol Res Pract; 1999 Dec 17; 195(11):747-52. PubMed ID: 10605694
    [Abstract] [Full Text] [Related]

  • 57. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
    Gunduz E, Gunduz M, Ali MA, Beder L, Tamamura R, Katase N, Tominaga S, Yamanaka N, Shimizu K, Nagatsuka H.
    Cancer Invest; 2009 Jul 17; 27(6):661-8. PubMed ID: 19488910
    [Abstract] [Full Text] [Related]

  • 58. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
    Enomoto K, Mimura T, Harris DL, Joyce NC.
    Invest Ophthalmol Vis Sci; 2006 Oct 17; 47(10):4330-40. PubMed ID: 17003423
    [Abstract] [Full Text] [Related]

  • 59. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.
    Liggett WH, Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D.
    Cancer Res; 1996 Sep 15; 56(18):4119-23. PubMed ID: 8797577
    [Abstract] [Full Text] [Related]

  • 60. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss.
    Maestro R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L, Boiocchi M.
    Cancer Res; 1996 Mar 01; 56(5):1146-50. PubMed ID: 8640775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.